6PVB image
Deposition Date 2019-07-20
Release Date 2020-08-19
Last Version Date 2023-11-15
Entry Detail
PDB ID:
6PVB
Title:
The structure of NTMT1 in complex with compound 6
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
1.50 Å
R-Value Free:
0.22
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:AMINO GROUP-()-(2~{S})-2-azanylpropanal-()-ISOLEUCINE-()-ARGININE-()-LYSINE-()-PROLINE-()-AMINO-ACETALDEHYDE-()-9-(5-{[(3S)-3-amino-3-carboxypropyl](pentyl)amino}-5-deoxy-beta-L-arabinofuranosyl)-9H-purin-6-amine
Chain IDs:B (auth: A)
Chain Length:8
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polypeptide(L)
Molecule:N-terminal Xaa-Pro-Lys N-methyltransferase 1
Gene (Uniprot):NTMT1
Chain IDs:A (auth: B)
Chain Length:241
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues.
J.Med.Chem. 63 8419 8431 (2020)
PMID: 32605369 DOI: 10.1021/acs.jmedchem.0c00770

Abstact

The bisubstrate analogue strategy is a promising approach to develop potent and selective inhibitors for protein methyltransferases. Herein, the interactions of a series of bisubstrate analogues with protein N-terminal methyltransferase 1 (NTMT1) were examined to probe the molecular properties of the active site of NTMT1. Our results indicate that a 2-C to 4-C atom linker enables its respective bisubstrate analogue to occupy both substrate- and cofactor-binding sites of NTMT1, but the bisubstrate analogue with a 5-C atom linker only interacts with the substrate-binding site and functions as a substrate. Furthermore, the 4-C atom linker is the optimal and produces the most potent inhibitor (Ki,app = 130 ± 40 pM) for NTMT1 to date, displaying more than 3000-fold selectivity for other methyltransferases and even for its homologue NTMT2. This study reveals the molecular basis for the plasticity of the active site of NTMT1. Additionally, our study outlines general guidance on the development of bisubstrate inhibitors for any methyltransferases.

Legend

Protein

Chemical

Disease

Primary Citation of related structures